Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, …
Medical - Devices
CN, Wuhan [HQ]
002932.SZ/Financial Reporting
Income Statements
13 Sheets · Starting from 2011In Million CNY. Margins, Growth Rates In %
| Metric | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.00 | 7.00 | 25.00 | 57.00 | 95.00 | 140.00 | 165.00 | 176.00 | 181.00 | 959.00 | 2,829.00 | 10,530.00 | 749.00 | |
|
EPS
|
- - | 0.39 | 0.85 | 0.15 | 0.23 | 0.39 | 0.42 | 0.35 | 0.20 | 2.27 | 6.68 | 18.08 | 0.33 | |
| Diluted in mil. | - - | 0.39 | 0.85 | 0.15 | 0.23 | 0.39 | 0.42 | 0.35 | 0.20 | 2.27 | 6.68 | 18.08 | 0.33 | |
|
Profit
|
- - | 4.00 | 18.00 | 41.00 | 75.00 | 120.00 | 135.00 | 135.00 | 134.00 | 750.00 | 2,122.00 | 7,039.00 | 406.00 | |
| Gross Margin | 62.00 | 58.80 | 70.59 | 71.23 | 78.95 | 85.54 | 81.86 | 77.10 | 74.32 | 78.21 | 75.02 | 66.85 | 54.28 | |
| Pre Tax | - - | 1.00 | 8.00 | 24.00 | 41.00 | 69.00 | 75.00 | 70.00 | 46.00 | 556.00 | 1,694.00 | 5,076.00 | 139.00 | |
| Profit Margin | 19.66 | 21.94 | 33.29 | 43.05 | 43.52 | 49.02 | 45.68 | 40.16 | 25.70 | 58.04 | 59.88 | 48.21 | 18.66 | |
| ETR | -5.74 | 9.96 | 15.23 | 13.45 | 14.21 | 13.63 | 13.09 | 11.81 | 8.69 | 14.56 | 14.63 | 13.71 | 50.52 | |
| Net | - - | 1.00 | 7.00 | 21.00 | 35.00 | 59.00 | 65.00 | 61.00 | 41.00 | 468.00 | 1,413.00 | 4,208.00 | 74.00 | |
| Profit Margin | 20.79 | 19.76 | 28.22 | 37.26 | 37.34 | 42.34 | 39.66 | 34.82 | 22.92 | 48.89 | 49.94 | 39.97 | 10.00 | |
| EBITDA | - - | 1.00 | 8.00 | 25.00 | 42.00 | 70.00 | 85.00 | 85.00 | 63.00 | 580.00 | 1,741.00 | 6,152.00 | 304.00 | |
| EBITDA Margin | 32.77 | 25.53 | 33.94 | 44.83 | 44.12 | 50.24 | 51.76 | 48.42 | 35.31 | 60.57 | 61.55 | 58.43 | 40.57 | |
| Operating Income | - - | 1.00 | 8.00 | 22.00 | 41.00 | 67.00 | 75.00 | 68.00 | 41.00 | 562.00 | 1,697.00 | 5,079.00 | 145.00 | |
| Operating Margin | -20.07 | 17.97 | 32.04 | 38.52 | 43.23 | 47.59 | 45.82 | 38.72 | 22.93 | 58.63 | 60.00 | 48.24 | 19.37 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | 1.00 | 3.00 | 4.00 | 11.00 | 17.00 | 4.00 | |
| Loss | -1.00 | -5.00 | -17.00 | -35.00 | -54.00 | -74.00 | -90.00 | -111.00 | -146.00 | -394.00 | -1,117.00 | -4,506.00 | -649.00 | |
| Cost of Revenue | - - | -2.00 | -7.00 | -16.00 | -20.00 | -20.00 | -29.00 | -40.00 | -46.00 | -208.00 | -707.00 | -3,491.00 | -342.00 | |
|
Operating Expenses
|
- - | -2.00 | -10.00 | -19.00 | -34.00 | -54.00 | -61.00 | -71.00 | -100.00 | -185.00 | -410.00 | -1,015.00 | -306.00 | |
| R&D | - - | - - | -2.00 | -3.00 | -8.00 | -20.00 | -25.00 | -27.00 | -36.00 | -69.00 | -132.00 | -388.00 | -141.00 | |
| G&A | - - | -1.00 | -3.00 | -1.00 | -6.00 | -4.00 | -4.00 | -7.00 | -6.00 | -10.00 | -25.00 | -30.00 | -38.00 | |
| SG&A | - - | -2.00 | -9.00 | -13.00 | -22.00 | -28.00 | -33.00 | -44.00 | -53.00 | -102.00 | -223.00 | -480.00 | -154.00 | |
| S&M | - - | -1.00 | -5.00 | -11.00 | -16.00 | -24.00 | -28.00 | -37.00 | -47.00 | -92.00 | -197.00 | -450.00 | -115.00 | |
| Depreciation and Amortization | - - | - - | - - | - - | -1.00 | -4.00 | -9.00 | -13.00 | -16.00 | -17.00 | -23.00 | -59.00 | -83.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -2.00 | -3.00 | -10.00 | |
| Other Expenses | - - | - - | - - | -2.00 | -1.00 | -2.00 | -1.00 | -5.00 | -5.00 | -5.00 | -3.00 | -3.00 | -5.00 | |
|
WA Shares Outstanding
|
60.00 | 3.00 | 8.00 | 142.00 | 151.00 | 154.00 | 155.00 | 176.00 | 206.00 | 206.00 | 211.00 | 232.00 | 227.00 | |
| Diluted | 60.00 | 3.00 | 8.00 | 142.00 | 151.00 | 154.00 | 155.00 | 176.00 | 206.00 | 206.00 | 211.00 | 232.00 | 227.00 |